Marksans Pharma’s arm gets EIR from USFDA for New York facility

30 Jun 2025 Evaluate

Marksans Pharma’s subsidiary -- Time-Cap Laboratories Inc has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its manufacturing facility located at Michael Avenue, Farmingdale, New York, USA. Current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA from April 16, 2025 to April 24, 2025. 

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

179.75 -0.40 (-0.22%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×